South Korean scientists have developed a method using mussel adhesive protein to connect severed nerve ends without the need to use suture threads.
A joint research team from Pohang University of Science and Technology, Ewha Woman's University, and the Catholic University of Korea Seoul St. Mary’s Hospital announced that it had developed a hydrogel adhesive for medical use based on mussel adhesive protein.
Nerves are one of the more difficult tissues to replicate. As a result, when they are cut, the only option to rejoin them is to carefully sew them together with suture threads.
This approach, however, necessitates a high level of medical expertise and takes a long time. Furthermore, there is a possibility that the secondary injury induced by suture thread penetration will impede nerve cell proliferation.
The researchers aimed to address these issues by transforming mussel adhesive protein into a jelly-like photo-crosslinking hydrogel adhesive.
The protein secreted by mussels to adhere to the moist surfaces of solid rocks is known as mussel adhesive protein.
When not exposed to light, this adhesive lives as a liquid. When exposed to visible light, it rapidly transforms into a hydrogel with sticky properties.
The use of this glue to connect severed nerve segments helps to avoid further injury and minimize immunological inflammation.


FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Tabletop particle accelerator could transform medicine and materials science
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 



